OTCPK:ORPE.F

Stock Analysis Report

Executive Summary

ORPEA Société Anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.

Snowflake

Fundamentals

Average dividend payer with acceptable track record.


Similar Companies

Share Price & News

How has ORPEA Société Anonyme's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

ORPE.F

-0.04%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

ORPE.F

-9.1%

US Healthcare

0.6%

US Market

No trading data on ORPE.F.

No trading data on ORPE.F.


Share holder returns

ORPE.FIndustryMarket
7 Day0%-0.04%-0.6%
30 Day3.5%-0.5%2.2%
90 Day7.6%-1.6%1.1%
1 Yearn/a-7.7%-9.1%2.9%0.6%
3 Year43.2%43.2%29.6%24.3%44.6%35.2%
5 Year94.6%94.6%66.1%56.2%61.9%44.2%

Price Volatility Vs. Market

How volatile is ORPEA Société Anonyme's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is ORPEA Société Anonyme undervalued based on future cash flows and its price relative to the stock market?

32.03x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

ORPEA Société Anonyme's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

ORPEA Société Anonyme's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

ORPEA Société Anonyme is overvalued based on earnings compared to the US Healthcare industry average.

ORPEA Société Anonyme is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

ORPEA Société Anonyme is poor value based on expected growth next year.


Price Based on Value of Assets

ORPEA Société Anonyme is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is ORPEA Société Anonyme expected to perform in the next 1 to 3 years based on estimates from 13 analysts?

11.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

ORPEA Société Anonyme's revenue is expected to grow by 6.1% yearly, however this is not considered high growth (20% yearly).

ORPEA Société Anonyme's earnings are expected to grow by 11.8% yearly, however this is not considered high growth (20% yearly).

ORPEA Société Anonyme's revenue growth is positive but not above the United States of America market average.

ORPEA Société Anonyme's earnings growth is positive but not above the United States of America market average.

ORPEA Société Anonyme's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

ORPEA Société Anonyme is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has ORPEA Société Anonyme performed over the past 5 years?

14.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

ORPEA Société Anonyme's year on year earnings growth rate has been positive over the past 5 years.

ORPEA Société Anonyme's 1-year earnings growth exceeds its 5-year average (145.5% vs 14.3%)

ORPEA Société Anonyme's earnings growth has exceeded the US Healthcare industry average in the past year (145.5% vs 5.6%).


Return on Equity

ORPEA Société Anonyme has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

ORPEA Société Anonyme used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

ORPEA Société Anonyme's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is ORPEA Société Anonyme's financial position?


Financial Position Analysis

ORPEA Société Anonyme's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

ORPEA Société Anonyme's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

ORPEA Société Anonyme's level of debt (197.8%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (160.7% vs 197.8% today).

Debt is not well covered by operating cash flow (7.1%, less than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 4.2x coverage).


Balance Sheet

High level of physical assets or inventory.

Debt is not covered by short term assets, assets are 0.3x debt.


Next Steps

Dividend

What is ORPEA Société Anonyme's current dividend yield, its reliability and sustainability?

1.33%

Expected Dividend Yield


Dividend Yield and Payments Analysis

ORPEA Société Anonyme's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

ORPEA Société Anonyme's dividend is below the markets top 25% of dividend payers in United States of America (3.71%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (2.8x coverage).


Future Payout to Shareholders

Dividends after 3 years are expected to be well covered by earnings (3.1x coverage).


Next Steps

Management

What is the CEO of ORPEA Société Anonyme's salary, the management and board of directors tenure and is there insider trading?

3.7yrs

Average board tenure


CEO

Yves Le Masne (57yo)

8.6yrs

Tenure

€7,217,567

Compensation

Mr. Yves Le Masne has been the Chief Executive Officer of ORPEA Société Anonyme since February 15, 2011 and served as its Chief Financial Officer and Chief Operating Officer since 2006. Previously, Mr. Le  ...


CEO Compensation Analysis

Yves's remuneration is about average for companies of similar size in United States of America.

Yves's compensation has been consistent with company performance over the past year, both up more than 20%.


Board Age and Tenure

3.7yrs

Average Tenure

61.5yo

Average Age

The tenure for the ORPEA Société Anonyme board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Yves Le Masne (57yo)

    CEO & Director

    • Tenure: 8.6yrs
    • Compensation: €7.22m
  • Jean-Claude Brdenk (52yo)

    Chief Operating Officer

    • Tenure: 8.6yrs
    • Compensation: €2.02m
  • Steve Grobet

    Head of Investor Relations

    • Tenure: 0yrs
  • Yamina Emmungil

    Head of Legal Affairs

    • Tenure: 0yrs

Board Members

  • Xavier Coirbay (54yo)

    Director

    • Tenure: 2.3yrs
    • Compensation: €41.56k
  • Yves Le Masne (57yo)

    CEO & Director

    • Tenure: 8.6yrs
    • Compensation: €7.22m
  • Philippe Charrier (65yo)

    Non-Executive Chairman

    • Tenure: 2.5yrs
    • Compensation: €817.56k
  • Thierry de Poncheville (64yo)

    Independent Director

    • Tenure: 7.6yrs
    • Compensation: €58.56k
  • Jean-Claude Marian (80yo)

    Honorary Chairman

    • Tenure: 2.5yrs
    • Compensation: €1.72m
  • Jean-Patrick Fortlacroix (62yo)

    Independent Director

    • Tenure: 8.3yrs
    • Compensation: €51.56k
  • Bernadette Chevallier-Danet (61yo)

    Independent Director

    • Tenure: 5yrs
    • Compensation: €42.06k
  • Sophie Kalaidjian (42yo)

    Director

    • Tenure: 4.7yrs
    • Compensation: €9.50k
  • Laure Baume (44yo)

    Director

    • Tenure: 2.8yrs
    • Compensation: €39.56k
  • Brigitte Lantz (66yo)

    Director

    • Tenure: 2.8yrs
    • Compensation: €37.56k

Company Information

ORPEA Société Anonyme's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ORPEA Société Anonyme
  • Ticker: ORPE.F
  • Exchange: OTCPK
  • Founded: 1989
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €7.059b
  • Listing Market Cap: €7.767b
  • Shares outstanding: 64.59m
  • Website: https://www.orpea-corp.com

Number of Employees


Location

  • ORPEA Société Anonyme
  • 12 rue Jean Jaruès
  • CS 10032
  • Puteaux
  • Ile-de-France
  • 92813
  • France

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ORPENXTPA (Euronext Paris)YesOrdinary SharesFREURApr 2002
OPADB (Deutsche Boerse AG)YesOrdinary SharesDEEURApr 2002
0NEXLSE (London Stock Exchange)YesOrdinary SharesGBEURApr 2002
ORPE.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDApr 2002
ORPPBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURApr 2002

Biography

ORPEA Société Anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing care facilities provide personalized support servic ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 00:10
End of Day Share Price2019/08/29 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.